REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genomic Health, Inc. (NQ: GHDX)
33.95 USD  -0.10 (-0.29%)
Streaming Delayed Price  /  Updated: 9:30 AM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Genomic Health, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Genomic Health (GHDX) Prostate Test Shows Encouraging Signs - Analyst
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8426615 for the full story. Read More
from StreetInsider.com News Articles
BofA/Merrill Lynch Downgrades Genomic Health Inc. (GHDX) to Neutral
June 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8425388 for the full story. Read More
from StreetInsider.com News Articles
7 Biotechnology Stocks to Sell Now
June 12, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
June 07, 2013
from PR Newswire
7 Biotechnology Stocks to Sell Now
June 05, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
UPDATE: Jefferies Assumes Coverage on Genomic Health at Hold Awaiting Profitability
May 31, 2013
In a report published Friday, Jefferies analyst Brandon Couillard assumed coverage on Genomic Health (NASDAQ: GHDX ) with a Hold rating, and raised the price target from $32.00 to $35.00. In the... Read More
category GHDX , Brandon Couillard , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2013
Prognostic Information from Oncotype DX in Metastatic Breast Cancer Indicates Importance of Biology Revealed by the Test Across Continuum of the Disease Read More
from PR Newswire
Jefferies Assumes Genomic Health Inc. (GHDX) at Hold
May 31, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8381325 for the full story. Read More
from StreetInsider.com News Articles
Genomic Health: 52-Week High Recently Eclipsed (GHDX)
May 30, 2013
from Comtex SmarTrend® News Briefs
7 Biotechnology Stocks to Sell Now
May 29, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Genomic Health to Present at Two Upcoming Investor Conferences
May 28, 2013
from PR Newswire
Watch for Continued Gains in Shares of Genomic Health (GHDX)
May 28, 2013
from Comtex SmarTrend® News Briefs
Watch for Continued Gains in Shares of Genomic Health (GHDX)
May 22, 2013
from Comtex SmarTrend® News Briefs
8 Biotechnology Stocks to Sell Now
May 22, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 21, 2013
from PR Newswire
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Genomic Health Is Up 22.6% (GHDX)
May 20, 2013
from Comtex SmarTrend® News Briefs
U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
May 18, 2013
Insiders may sell shares for any number of reasons, but conventional wisdom is that insiders really only buy shares of a company for one reason -- they believe the stock price will move higher and they... Read More
category GHDX , Benzinga , Murphy Oil , and 35 more.
from Latest Articles from Benzinga.com
New cancer tools allow patients to reconsider chemo
May 15, 2013
LOS ANGELES, May 15 (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh... Read More
category companyNews
from Reuters: Company News
7 Biotechnology Stocks to Sell Now
May 15, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
StreetInsider.com Pre-Open Movers 5/14: (SNE) (TSLA) (FIO) Higher; (MOSY) (SCTY) (TSL) Lower (more...)
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8335108 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com After-Hours Movers 05/13: (TTWO) (PSDV) Higher; (MOSY) (SCTY) (GHDX) Lower (more...)
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8332688 for the full story. Read More
from StreetInsider.com News Articles
Genomic Health (GHDX) Files 10M Common Shelf
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8332574 for the full story. Read More
from StreetInsider.com News Articles
Genomic Health (GHDX) Oncotype DX Coverage Expanded for Medicare Patients
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8327964 for the full story. Read More
from StreetInsider.com News Articles
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test
May 10, 2013
Genomic Health, Inc. (Nasdaq: GHDX ) today announced that, effective May 8, 2013, Palmetto GBA, the designated national contractor for its Oncotype DX® breast cancer test, has expanded its coverage... Read More
category GHDX , Benzinga , News , and 1 more.
from Latest Articles from Benzinga.com
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis
May 10, 2013
from PR Newswire
NASDAQ Gainers Watch List: Accuray Incorporated (NASDAQ:ARAY), Genomic Health Inc. (NASDAQ:GHDX), and Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) Added to Growing Stock Report's NASDAQ Gainers Watch List
May 08, 2013
New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Accuray Incorporated (NASDAQ:ARAY), Genomic Health Inc. (NASDAQ:GHDX), and Onyx... Read More
from SBWire - Latest Press Releases
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Inva
May 08, 2013
Groundbreaking Results from University of California, San Francisco (UCSF) Clinical Validation Study Presented at American Urological Association (AUA) Annual Meeting Read More
from PR Newswire
7 Biotechnology Stocks to Sell Now
May 08, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test
May 08, 2013
Genomic Health, Inc. (Nasdaq: GHDX ) is making its Oncotype DX® prostate cancer test available to physicians and their patients today following the presentation by the University of California, San... Read More
category Contracts , Management , GHDX , and 4 more.
from Latest Articles from Benzinga.com
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Inva
May 08, 2013
Groundbreaking Results from University of California, San Francisco (UCSF) Clinical Validation Study Presented at American Urological Association (AUA) Annual Meeting Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here